|
All patients (n=29) |
Survivors (n=21) |
Deaths (n=8) |
P |
| β blockers n (%) |
28 (96.5) |
20 (95.2) |
8 (100) |
NSa |
| ACE-I n (%) |
27 (93.1) |
20 (95.2) |
7 (87.5) |
NSa |
| ARB n (%) |
14 (48.3) |
11 (52.4) |
3 (37.5) |
NSa |
| Digitalis n (%) |
21 (72.4) |
15 (71.4) |
6 (75.0) |
NSa |
| Spironolactone n (%) |
26 (89.6) |
19 (90.5) |
7 (87.5) |
NSa |
| Loop diuretics n (%) |
21 (79.6) |
14 (66.7) |
7 (87.5) |
NSa |
| Statins n (%) |
13 (44.8) |
10 (47.6) |
3 (37.5) |
NSa |
Data presented are absolute numbers and percentages
aΧ2 test
ACE-I:Angiotensin Converting Enzyme Inhibitors
ARB:Angiotensin Receptor Blockers |
|
